Research strategy 2025: our areas of investment

Our four areas of investment relate to our four different funding schemes.

Discovery and translational research focuses on exploring how diseases work and applying this knowledge to come up with new potential treatments.

We will:

• Increase funding for discovery research across the UK by supporting Project and Pilot grants, and Fellowships, to help find breakthroughs for all types of blood cancer.
• Continue funding Transformational Research Awards to turn early discoveries into therapies for testing in people.
• Work with expert partners to bring new treatments to people with blood cancer faster.

Clinical research involves testing new treatments in people living with the disease.

We will:

• Invest £24 million in large, innovative clinical trials to find new treatments for the hardest-to-treat blood cancers.
• Support collecting and analysing samples during clinical trials to better understand how treatments work and who benefits most.
• Identify and reduce the barriers that slow down clinical trials in the UK to speed up research into blood cancer.
• Create ways to help more people, especially those groups of people who are less likely to take part in clinical trials.

This will be achieved through our research funding schemes such as our Transformational Research Awards.

Funding and supporting researchers' careers to develop and retain the best people in the field.

We will:

• Fund PhD training and grants (e.g. our Early Career Advancement Fellowships) for new researchers to help fill critical gaps in research.
• Support early-career researchers by helping them apply for other funding, attend conferences, and build professional networks.
• Offer specialist funding so healthcare professionals can lead research in their own patient communities.
• Spread research funding more fairly across the UK.

Working with other organisations and experts who share our goals.

We will:

• Fill the gaps in our funding programme and make the most of the funds we have.
• Work together by sharing our expertise and learning from others, so we can reach our goals faster.
• Invite scientists from other areas to help with blood cancer research, bringing new ideas to old challenges.
• Develop partnerships focused on childhood blood cancer, rare conditions, and turning research into real-world treatments.